Saltar al contenido
Slide

An understanding of disease processes drives innovation in medicine

Slide

«A thinker sees his own actions as experiments
and questions, as attempts to find out something.
Success and failure are for him answers above all.»

Slide

«There is one thing even more vital to science than intelligent
methods; and that is the sincere desire to find out the truth,
whatever it may be.»

– Charles Pierce

Slide

«Every great advance in science has issued
from a new audacity of imagination»

– John Dewey

Slide

«Somewhere, something incredible is waiting to be known»

– Carl Sagan

Slide

«There is nothing which can better deserve your patronage
than the promotion of science and literature. Knowledge is in every country the surest basis of public happiness.»

– George Washington

Slide

«Learn from yesterday, live for today, hope for tomorrow
The important thing is to not stop questioning.»

– Albert Einstein

previous arrow
next arrow

Welcome

Welcome to the website of the CellCOM Research Group. Our group is a translational and clinical research group within the Center for Research in Nanomaterials and Biomedicine (CINBIO). Our approaches combine in vitro, ex vivo and in vivo models to conduct pre-clinical studies in age-related diseases and cancer. Our group is a multidisciplinary team that includes basic scientists (predoctoral, postdoctoral fellows and technicians) and clinical researchers such as pathologists, dermatologists, radiologists and surgeons.

Our aims are to understand the physiopathology of connexin-linked diseases (cancer, inflammation, tissue degeneration), to design molecules and new drugs that modulate the activity of specific targets and to identify novel markers of disease prevention, diagnosis and disease management.

We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, metastasis and resistance to targeted cancer therapies and immunotherapies. Our final goal is to identify effective therapeutic targets to design specific and successful therapeutic approaches to treat these disorders.

Follow us on Twitter to stay updated on news


“Francisco Guitián Ojea” Award I RAGC

“Francisco Guitián Ojea” Award I RAGC

Jul 27, 2020

July 2020 Galician Royal Academy of Sciences (RAGC) Awards Thanks to RAGC…

EMBO Short-Term Fellowship

EMBO Short-Term Fellowship

Jul 27, 2020

April 2020 EMBO Short-Term Fellowship Thanks to EMBO for the…

María Mayán at the Governing bodies of SEBBM

María Mayán at the Governing bodies of SEBBM

May 26, 2020

July 2020 New Boards of Directors at SEBBM The Governing…

Woman in Science: presentation of ASEICA Mujer in Bilbao

Woman in Science: presentation of ASEICA Mujer in Bilbao

Ene 18, 2020

Oct 2019 ASEICA Mujer – Spanish Association for Cancer Research (ASEICA)…

Women in Science I AECC-Coruña

Women in Science I AECC-Coruña

Ene 17, 2020

January 2020 AECC-Coruña «Con nombre de mujer: Ciencia a pie…

Connexin and pannexin channels in inflammation, tissue regeneration and cancer

Connexin and pannexin channels in inflammation, tissue regeneration and cancer

Oct 18, 2019

Oct 2019 Science Xpression 2019 Seventh edition of Science Xpression…